Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
52 week high
|
Strong Performer, Getting Expensive
1155.2000
5.10
(
0.44
%)
NSE
May 07, 2026
15:31 PM
New 52W High today
Volume:
412.4K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
05 Dec 2022
52 week high
1155.20
0.44%
NATCO PHARMA
Buy:
Natco Pharma Ltd.
by
Geojit BNP Paribas
Target: 704
Recommendation
Target
Geojit BNP Paribas
Natco Pharma Ltd. has an
average target
of 904.00 from 2 brokers.
More from Natco Pharma Ltd.
Recommended
Market closes flat as caution persists amid foreign fund outflows
Trendlyne Marketwatch |
07 May 2026, 03:57PM
What drove multibaggers in FY26: Order books, commodity cycles and turnaround plays
The Baseline |
07 May 2026, 01:14PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020